Insider · CIK 0001255927
Kania Edwin
Reports to the SEC for 23 companies · ANDOVER, MA
Transactions
50
Companies
23
Filings
10
CIK
0001255927
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-05-20 | TMDXTransMedics Group, Inc.A Award | — |
| 2025-05-22 | TMDXTransMedics Group, Inc.A Award | — |
| 2024-05-23 | TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-05-23 | TMDXTransMedics Group, Inc.A Award | — |
| 2023-05-25 | TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2023-05-25 | TMDXTransMedics Group, Inc.A Award | — |
| 2023-02-28 | TMDXTransMedics Group, Inc.J Other | +$11.6M |
| 2023-02-28 | TMDXTransMedics Group, Inc.J Other | +$7.73M |
| 2022-06-01 | TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-11-29 | TMDXTransMedics Group, Inc.P Purchase | +$1.68M |
| 2021-11-29 | TMDXTransMedics Group, Inc.P Purchase | +$574K |
| 2021-11-19 | TMDXTransMedics Group, Inc.J Other | — |
| 2021-11-19 | TMDXTransMedics Group, Inc.J Other | — |
| 2021-11-17 | TMDXTransMedics Group, Inc.G Gift | — |
| 2021-11-17 | TMDXTransMedics Group, Inc.J Other | — |
| 2021-11-17 | TMDXTransMedics Group, Inc.J Other | — |
| 2021-11-17 | TMDXTransMedics Group, Inc.J Other | — |
| 2021-05-27 | TMDXTransMedics Group, Inc. · Stock Option (Right to Buy)A Award | — |
| 2020-01-14 | MRNAModerna, Inc.S Sale | −$2.35M |
| 2020-01-10 | MRNAModerna, Inc.S Sale | −$7.27M |
| 2019-12-12 | TMDXTransMedics Group, Inc.J Other | — |
| 2019-12-12 | TMDXTransMedics Group, Inc.J Other | — |
| 2019-12-10 | MRNAModerna, Inc.S Sale | −$1.88M |
| 2019-10-29 | TMDXTransMedics Group, Inc.J Other | — |
| 2019-10-29 | TMDXTransMedics Group, Inc.J Other | — |
| 2019-05-06 | TMDXTransMedics Group, Inc. · Series C Convertible Preferred StockC Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc. · Series B-1 Convertible Preferred StockC Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc. · Series A-1 Convertible Preferred StockC Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc.P Purchase | +$533K |
| 2019-05-06 | TMDXTransMedics Group, Inc. · Series D Convertible Preferred StockC Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc.C Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc.C Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc.C Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc.J Other | — |
| 2019-05-06 | TMDXTransMedics Group, Inc.J Other | — |
| 2019-05-06 | TMDXTransMedics Group, Inc.J Other | — |
| 2019-05-06 | TMDXTransMedics Group, Inc.J Other | — |
| 2019-05-06 | TMDXTransMedics Group, Inc. · Series D Convertible Preferred StockC Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc. · Series D Convertible Preferred StockC Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc. · Series C Convertible Preferred StockC Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc. · Series B-1 Convertible Preferred StockC Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc. · Series A-1 Convertible Preferred StockC Conversion | — |
| 2019-05-06 | TMDXTransMedics Group, Inc. · Series F Convertible Preferred StockC Conversion | — |
| 2017-05-16 | RNACCartesian Therapeutics, Inc.S Sale | −$3.74M |
| 2016-06-27 | RNACCartesian Therapeutics, Inc. · Series E Convertible Preferred StockC Conversion | — |
| 2016-06-27 | RNACCartesian Therapeutics, Inc. · Series D Convertible Preferred StockC Conversion | — |
| 2016-06-27 | RNACCartesian Therapeutics, Inc. · Series C Convertible Preferred StockC Conversion | — |
| 2016-06-27 | RNACCartesian Therapeutics, Inc. · Series B Convertible Preferred StockC Conversion | — |
| 2016-06-27 | RNACCartesian Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion | — |
| 2016-06-27 | RNACCartesian Therapeutics, Inc.C Conversion | — |
Recent filings
- 4Kania Edwin0001193125-26-236904SEC(opens sec.gov)
- 4KANIA EDWIN M JR0000950170-25-077213SEC(opens sec.gov)
- 4KANIA EDWIN M JR0000950170-24-065396SEC(opens sec.gov)
- 4KANIA EDWIN M JR0000950170-23-024894SEC(opens sec.gov)
- 4KANIA EDWIN M JR0000899243-23-006756SEC(opens sec.gov)
- 4KANIA EDWIN M JR0000899243-22-021201SEC(opens sec.gov)
- 4KANIA EDWIN M JR0000899243-21-046299SEC(opens sec.gov)
- 4KANIA EDWIN M JR0000899243-21-045464SEC(opens sec.gov)
- 4KANIA EDWIN M JR0000899243-21-021355SEC(opens sec.gov)
- 4KANIA EDWIN M JR0000899243-20-001179SEC(opens sec.gov)
Companies
- ACCELERON PHARMA INCDirector
- AGIOS PHARMACEUTICALS, INC.10% OwnerAGIO
- ASPECT MEDICAL SYSTEMS INCDirector
- Axcella Health Inc.10% Owner
- BG Medicine, Inc.10% Owner
- Carisma Therapeutics Inc.10% OwnerCARM
- Cartesian Therapeutics, Inc.DirectorRNAC
- CONCERT PHARMACEUTICALS, INC.10% Owner
- DNIB UNWIND, INC.10% Owner
- Editas Medicine, Inc.10% OwnerEDIT
- Evelo Biosciences, Inc.10% Owner
- EXACT SCIENCES CORPDirectorEXAS
- HELICOS BIOSCIENCES CORP10% Owner
- Kaleido Biosciences, Inc.10% Owner
- Moderna, Inc.10% OwnerMRNA
- Quanterix Corp10% OwnerQTRX
- Receptos, Inc.10% Owner
- Rubius Therapeutics, Inc.10% Owner
- Seres Therapeutics, Inc.10% OwnerMCRB
- Syros Pharmaceuticals, Inc.10% Owner
- T2 Biosystems, Inc.10% Owner
- TETRAPHASE PHARMACEUTICALS INC10% Owner
- TransMedics Group, Inc.DirectorTMDX
Address
C/O TRANSMEDICS GROUP, INC. 200 MINUTEMAN ROAD
ANDOVER, MA, 01810